Migle Kazlauskiene

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 6

Top Topics

Molecularly Imprinted

Binding Protein

Capillary Electrophoresis

Top Venues

Expert opinion on drug discovery

Science (New York, N.Y.)

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Visvaldas Kairys, Lina Baranauskienė, Migle Kazlauskiene, Asta Zubrienė, Vytautas Petrauskas, Daumantas Matulis, Egidijus Kazlauskas
Recent advances in computational and experimental protein-ligand affinity determination techniques. Expert opinion on drug discovery 19 (6) (2024)
Visvaldas Kairys, Lina Baranauskienė, Migle Kazlauskiene, Asta Zubrienė, Vytautas Petrauskas, Daumantas Matulis, Egidijus Kazlauskas
Recent advances in computational and experimental protein-ligand affinity determination techniques. Expert opinion on drug discovery 19 (6) (2024)
Visvaldas Kairys, Lina Baranauskienė, Migle Kazlauskiene, Asta Zubrienė, Vytautas Petrauskas, Daumantas Matulis, Egidijus Kazlauskas
Recent advances in computational and experimental protein-ligand affinity determination techniques. Expert opinion on drug discovery (2024)
Praveen Bawankar, Tina Lence, Chiara Paolantoni, Irmgard U Haussmann, Migle Kazlauskiene, Dominik Jacob, Jan B Heidelberger, Florian M Richter, Mohanakarthik P Nallasivan, Violeta Morin, Nastasja Kreim, Petra Beli, Mark Helm, Martin Jinek, Matthias Soller, Jean-Yves Roignant
Hakai is required for stabilization of core components of the m6A mRNA methylation machinery. Nature communications 12 (1) (2021)
Visvaldas Kairys, Lina Baranauskienė, Migle Kazlauskiene, Daumantas Matulis, Egidijus Kazlauskas
Binding affinity in drug design: experimental and computational techniques. Expert opinion on drug discovery 14 (8) (2019)
Migle Kazlauskiene, Georgij Kostiuk, Česlovas Venclovas, Gintautas Tamulaitis, Virginijus Siksnys
A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems. Science (New York, N.Y.) 357 (6351) (2017)